(
out of
358
reviews
)
Board Certification
|
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Adult Congenital Heart Disease)
American Board of Internal Medicine (Sub: Cardiovascular Disease)
Fellow of Royal College of Physicians of Canada
National Board of Echocardiography
|
Patient Rating
Patients consistently describe Dr. Whitehead as knowledgeable and an expert in HHT who takes time to explain conditions and treatment plans clearly. Commenters highlight that he listens well, is caring and attentive, and makes patients feel respected and included in decision-making. Many reviews also praise his thoroughness and the helpfulness of his staff.
Generated via Patient Reviews
4.9
/5
( out of
358 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Associate Professor Pediatrics -Adjunct Associate Professor |
|---|---|
| Academic Divisions |
Cardiovascular Medicine
Cardiology |
| Board Certification |
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Adult Congenital Heart Disease)
American Board of Internal Medicine (Sub: Cardiovascular Disease)
Fellow of Royal College of Physicians of Canada
National Board of Echocardiography
|
Education history
| Fellowship | Cardiology - University of Utah School of Medicine | Fellow |
|---|---|---|
| Residency | Internal Medicine - University of Western Ontario | Resident |
| Internship | Internal Medicine - University of Western Ontario | Intern |
| Professional Medical | Medicine - University of Alberta - School of Medicine | M.D. |
| Undergraduate | Medical Science - University of Alberta | B.Med.Sci. |
| Undergraduate | Biochemistry - University of Lethbridge | |
| Undergraduate | Pre-Medicine - University of Lethbridge |
Selected Publications
Journal Article
- Al-Samkari H, Friday C, Kasthuri RS, Gossage JR, Murphy CG, Hountras P, Smith KL, Kirkland K, Iyer V, Prasad V, Ahluwalia V, Rodriguez-Lopez J, Witkin AS, Conrad M, Hetts S, Ohliger M, Chakinala M, Sisk BA, Beasley MA, Kirkpatrick P, Lindquist J, Battaile JT, Lu A, Parambil J, McCrae K, Sheynzon V, Whitehead K, Sion C, McWilliams J, Cusumano LR, Trerotola SO, Drivas TG, Chesnutt M, Kaufman C, Dickey M, Boyce D, Krock N, Cottrill C, Competiello T, Levy H, Clancy M, Henderson K, Pollak JS (2026). Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS). Blood, 148(4), 417-432.
- Crume TL, Khanna AD, Tillman A, Lui GK, Soim AS, Hsu DT, Sommerhalter K, Sullivan A, Li JS, D Ottavio A 2nd, Book WM, Raskind-Hood C, Whitehead K, Pinto N, Feldkamp ML, Reeder MR, Krikov S, Botto LD (2026). Health Care Utilization in Adults With Congenital Heart Disease: Population-Based Findings. Birth Defects Res, 118(6), e70063.
- Al-Samkari H, Thomas SM, Marsh D, Kasthuri RS, Iyer VN, Pishko AM, Decker JE, Weiss CR, Whitehead KJ, Conrad MB, Zumberg MS, Zhou JY, Parambil J, Carper B, Clancy M, McCrae KR (2026). Characteristics associated with clinical response to pomalidomide in hereditary hemorrhagic telangiectasia. Blood Adv, 10(9), 2967-2976.
- Zhang E, Kasthuri RS, Parambil J, Prasad V, Iyer VN, Whitehead KJ, Hodges PG, Pishko AM, Conrad MB, Phelan D, Rodriguez-Lopez J, McCrae KR, Al-Samkari H (2025). Pomalidomide for hereditary hemorrhagic telangiectasia: after trial longitudinal assessment study (PATH-HHT ATLAS). Blood Adv, 10(5), 1799-1808.
- Al-Samkari H, Kasthuri RS, Iyer VN, Pishko AM, Decker JE, Weiss CR, Whitehead KJ, Conrad MB, Zumberg MS, Zhou JY, Parambil J, Carper B, Clancy M, Thomas SM, McCrae KR (2025). Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale. J Thromb Haemost, 24(1), 108-118.
- Botto LD, Reeder MR, Lui GK, Glidewell MJ, Book WM, Crume TL, DeLaRosa JM, dOttavio A, Downing KF, Feldkamp ML, Hsu DT, Khanna AD, Krikov S, Pinto NM, Raskind Hood CL, Rodriguez FH 3rd, Soim AS, Whitehead KJ, Chiswell K, Li JS (2025). Comorbidity and Multimorbidity in Adults With Congenital Heart Disease: Findings From a Multi-Site Population-Based Study. Birth Defects Res, 117(8), e2515.
- Landstrom AP, Spears T, DOttavio A, Chiswell K, Sommerhalter K, Soim A, Farr SL, Crume T, Book WM, Whitehead K, Botto LD, Li JS, Hsu DT (2024). Cardiovascular disease risk factors in congenital heart disease survivors are associated with heart failure. Pediatr Res, 97(2), 700-706.
- Al-Samkari H, Kasthuri RS, Iyer VN, Pishko AM, Decker JE, Weiss CR, Whitehead KJ, Conrad MB, Zumberg MS, Zhou JY, Parambil J, Marsh D, Clancy M, Bradley L, Wisniewski L, Carper BA, Thomas SM, McCrae KR (2024). Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia. N Engl J Med, 391(11), 1015-1027.
- Steinberg BA, Tandar A, Whitehead KJ (2024). Helix-fixed leadless pacemaker implantation through a valve-in-valve tricuspid prosthesis via the femoral approach. J Interv Card Electrophysiol, 67(5), 915-917.
- Beslow LA, Vossough A, Kim H, Nelson J, Lawton MT, Pollak J, Lin DDM, Ratjen F, Hammill AM, Hetts SW, Gossage JR, Whitehead KJ, Faughnan ME, Krings T, Atherton ME, Chakinala MM, Clancy MS, Henderson K, Hetts SW, Hountras P, Iyer V, Kasthuri RS, Lin D, Mager JJ, Marchuk DA, McWilliams JP, McDonald J, Pawlikowska L, Swanson K, Vethanayagam D, Weinsheimer S, White AJ, Wilcox P (2024). Brain AVM compactness score in children with hereditary hemorrhagic telangiectasia. Childs Nerv Syst, 40(7), 2101-2108.
- Whitehead KJ, Toydemir D, Wooderchak-Donahue W, Oakley GM, McRae B, Putnam A, McDonald J, Bayrak-Toydemir P (2024). Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT). Int J Mol Sci, 25(14).
- Beslow LA, Krings T, Kim H, Hetts SW, Lawton MT, Ratjen F, Whitehead KJ, Gossage JR, McCulloch CE, Clancy M, Bagheri N, Faughnan ME, Faughnan ME, Chakinala MM, Clancy M, Hammill AM, Henderson K, Hetts SW, Hountras P, Iyer V, Kasthuri RS, Lin D, Mager JJ, Marchuk DA, McWilliams JP, McDonald J, Pawlikowska L, Pollak J, Swanson K, Vethanayagam D, Weinsheimer S, White AJ, Wilcox P (2024). De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia. Pediatr Neurol, 155, 120-125.
- Landstrom AP, Spears T, DOttavio A, Chiswell K, Sommerhalter K, Soim A, Farr SL, Crume T, Book WM, Whitehead K, Botto LD, Li JS, Hsu DT (2024). Cardiovascular disease risk factors in congenital heart disease survivors are associated with heart failure. Pediatr Res.
- Kilian A, Latino GA, White AJ, Ratjen F, McDonald J, Whitehead KJ, Gossage JR, Krings T, Lawton MT, Kim H, Faughnan ME, The Brain Vascular Malformation Consortium Hht Investigator Group (2023). Reply to Eker et al. Comment on "Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J. Clin. Med. 2023, 12, 2704". J Clin Med, 12(23).
- Sun B, Rouzbehani OMT, Kramer RJ, Ghosh R, Perelli RM, Atkins S, Fatahian AN, Davis K, Szulik MW, Goodman MA, Hathaway MA, Chi E, Word TA, Tunuguntla H, Denfield SW, Wehrens XHT, Whitehead KJ, Abdelnasser HY, Warren JS, Wu M, Franklin S, Boudina S, Landstrom AP (2023). Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice. Circ Heart Fail, 16(12), e010351.
- McDonald J, Kornish J, Stevenson DA, Hanson-Kahn A, Balch H, James J, Naik H, Whitehead KJ (2023). Frequency of epistaxis and telangiectasia in patients with hereditary hemorrhagic telangiectasia (HHT) in comparison with the general population: Curaçao diagnostic criteria revisited. Genet Med, 25(8), 100865.
- Kilian A, Latino GA, White AJ, Ratjen F, McDonald J, Whitehead KJ, Gossage JR, Krings T, Lawton MT, Kim H, Faughnan ME, The Brain Vascular Malformation Consortium Hht Investigator Group (2023). Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J Clin Med, 12(7).
- Kilian A, Latino GA, White AJ, Ratjen F, McDonald J, Whitehead KJ, Gossage JR, Krings T, Lawton MT, Kim H, Faughnan ME (2023). Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J Clin Med, 12(7).
- Kaufman CS, McDonald J, Balch H, Whitehead K (2022). Pulmonary Arteriovenous Malformations: What the Interventional Radiologist Should Know. Semin Intervent Radiol, 39(3), 261-270.
- Son SL, Hosek LL, Stein MC, Allshouse AA, Catino AB, Hoskoppal AK, Cox DA, Whitehead KJ, Lindsay IM, Esplin S, Metz TD (2021). Association between pregnancy and long-term cardiac outcomes in individuals with congenital heart disease. Am J Obstet Gynecol, 226(1), 124.e1-124.e8.
- Cho JM, Park SK, Ghosh R, Ly K, Ramous C, Thompson L, Hansen M, Mattera MSLC, Pires KM, Ferhat M, Mookherjee S, Whitehead KJ, Carter K, Buffolo M, Boudina S, Symons JD (2021). Late-in-life treadmill training rejuvenates autophagy, protein aggregate clearance, and function in mouse hearts. Aging Cell, 20(10), e13467.
- Shankar TS, Ramadurai DKA, Steinhorst K, Sommakia S, Badolia R, Thodou Krokidi A, Calder D, Navankasattusas S, Sander P, Kwon OS, Aravamudhan A, Ling J, Dendorfer A, Xie C, Kwon O, Cheng EHY, Whitehead KJ, Gudermann T, Richardson RS, Sachse FB, Schredelseker J, Spitzer KW, Chaudhuri D, Drakos SG (2021). Cardiac-specific deletion of voltage dependent anion channel 2 leads to dilated cardiomyopathy by altering calcium homeostasis. Nat Commun, 12(1), 4583.
- Andrade L, Hoskoppal A, Hunt Martin M, Whitehead K, Ou Z, Kuang J, Cox D (2020). Intracranial aneurysm and coarctation of the aorta: prevalence in the current era. Cardiol Young, 31(2), 229-232.
- Hart BL, Mabray MC, Morrison L, Whitehead KJ, Kim H (2021). Systemic and CNS manifestations of inherited cerebrovascular malformations. Clin Imaging, 75, 55-66.
- Faughnan ME, Mager JJ, Hetts SW, Palda VA, Lang-Robertson K, Buscarini E, Deslandres E, Kasthuri RS, Lausman A, Poetker D, Ratjen F, Chesnutt MS, Clancy M, Whitehead KJ, Al-Samkari H, Chakinala M, Conrad M, Cortes D, Crocione C, Darling J, de Gussem E, Derksen C, Dupuis-Girod S, Foy P, Geisthoff U, Gossage JR, Hammill A, Heimdal K, Henderson K, Iyer VN, Kjeldsen AD, Komiyama M, Korenblatt K, McDonald J, McMahon J, McWilliams J, Meek ME, Mei-Zahav M, Olitsky S, Palmer S, Pantalone R, Piccirillo JF, Plahn B, Porteous MEM, Post MC, Radovanovic I, Rochon PJ, Rodriguez-Lopez J, Sabba C, Serra M, Shovlin C, Sprecher D, White AJ, Winship I, Zarrabeitia R (2020). Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med, 173(12), 989-1001.
- Kilian A, Latino GA, White AJ, Clark D, Chakinala MM, Ratjen F, McDonald J, Whitehead K, Gossage JR, Lin D, Henderson K, Pollak J, McWilliams JP, Kim H, Lawton MT, Faughnan ME, Chakinala M, Clancy MS, Gossage JR, Henderson K, Iyer V, Kasthuri RS, Kim H, Krings T, Lawton MT, Lin D, Mager JJ, Marchuk DA, McWilliams JP, McDonald J, Pawlikowska L, Pollak J, Ratjen F, Swanson K, Vethanayagam D, Wilcox P (2020). Genotype–phenotype correlations in children with hht. J Clin Med, 9(9), 1-9.
- Kilian A, Latino GA, White AJ, Clark D, Chakinala MM, Ratjen F, McDonald J, Whitehead K, Gossage JR, Lin D, Henderson K, Pollak J, McWilliams JP, Kim H, Lawton MT, Faughnan ME, the Brain Vascular Malformation Consortium HHT Investigator Group (2020). Genotype-Phenotype Correlations in Children with HHT. J Clin Med, 9(9).
- McDonald J, Bayrak-Toydemir P, DeMille D, Wooderchak-Donahue W, Whitehead K (2020). Curaçao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2). Genet Med, 22(7), 1201-1205.
- Shanmugam G, Wang D, Gounder SS, Fernandes J, Litovsky SH, Whitehead K, Radhakrishnan RK, Franklin S, Hoidal JR, Kensler TW, DellItalia L, Darley-Usmar V, Abel ED, Jones DP, Ping P, Rajasekaran NS (2021). Reductive Stress Causes Pathological Cardiac Remodeling and Diastolic Dysfunction. Antioxid Redox Signal, 32(18), 1293-1312.
- Flemming KD, Kumar S, Brown RD Jr, Singh RJ, Whitehead K, McCreath L, Lanzino G (2020). Cavernous Malformation Hemorrhagic Presentation at Diagnosis Associated with Low 25-Hydroxy-Vitamin D Level. Cerebrovasc Dis, 49(2), 216-222.
- Polster SP, Stadnik A, Akers AL, Cao Y, Christoforidis GA, Fam MD, Flemming KD, Girard R, Hobson N, Koenig JI, Koskimki J, Lane K, Liao JK, Lee C, Lyne SB, McBee N, Morrison L, Piedad K, Shenkar R, Sorrentino M, Thompson RE, Whitehead KJ, Zeineddine HA, Hanley DF, Awad IA (2018). Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery, 85(6), 843-853.
- Tang AT, Sullivan KR, Hong CC, Goddard LM, Mahadevan A, Ren A, Pardo H, Peiper A, Griffin E, Tanes C, Mattei LM, Yang J, Li L, Mericko-Ishizuka P, Shen L, Hobson N, Girard R, Lightle R, Moore T, Shenkar R, Polster SP, Roedel CJ, Li N, Zhu Q, Whitehead KJ, Zheng X, Akers A, Morrison L, Kim H, Bittinger K, Lengner CJ, Schwaninger M, Velcich A, Augenlicht L, Abdelilah-Seyfried S, Min W, Marchuk DA, Awad IA, Kahn ML (2018). Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation. Sci Transl Med, 11(520).
- Gonzalez CD, Cipriano SD, Topham CA, Stevenson DA, Whitehead KJ, Vanderhooft S, Presson AP, McDonald J (2019). Localization and age distribution of telangiectases in children and adolescents with hereditary hemorrhagic telangiectasia: A retrospective cohort study. J Am Acad Dermatol, 81(4), 950-955.
- Wooderchak-Donahue WL, Akay G, Whitehead K, Briggs E, Stevenson DA, OFallon B, Velinder M, Farrell A, Shen W, Bedoukian E, Skrabann CM, Antaya RJ, Henderson K, Pollak J, Treat J, Day R, Jacher JE, Hannibal M, Bontempo K, Marth G, Bayrak-Toydemir P, McDonald J (2019). Phenotype of CM-AVM2 caused by variants in EPHB4: how much overlap with hereditary hemorrhagic telangiectasia (HHT)? Genet Med, 21(9), 2007-2014.
- Balakrishnan B, Verheijen J, Lupo A, Raymond K, Turgeon C, Yang Y, Carter KL, Whitehead KJ, Kozicz T, Morava E, Lai K (2019). A novel phosphoglucomutase-deficient mouse model reveals aberrant glycosylation and early embryonic lethality. J Inherit Metab Dis, 42(5), 998-1007.
- Lyne SB, Girard R, Koskimki J, Zeineddine HA, Zhang D, Cao Y, Li Y, Stadnik A, Moore T, Lightle R, Shi C, Shenkar R, Carrin-Penagos J, Polster SP, Romanos S, Akers A, Lopez-Ramirez M, Whitehead KJ, Kahn ML, Ginsberg MH, Marchuk DA, Awad IA (2019). Biomarkers of cavernous angioma with symptomatic hemorrhage. JCI Insight, 4(12).
- Wooderchak-Donahue WL, McDonald J, Farrell A, Akay G, Velinder M, Johnson P, VanSant-Webb C, Margraf R, Briggs E, Whitehead KJ, Thomson J, Lin AE, Pyeritz RE, Marth G, Bayrak-Toydemir P (2018). Genome sequencing reveals a deep intronic splicing ACVRL1 mutation hotspot in Hereditary Haemorrhagic Telangiectasia. J Med Genet, 55(12), 824-830.
- Girard R, Zeineddine HA, Koskimki J, Fam MD, Cao Y, Shi C, Moore T, Lightle R, Stadnik A, Chaudagar K, Polster S, Shenkar R, Duggan R, Leclerc D, Whitehead KJ, Li DY, Awad IA (2018). Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res, 122(12), 1716-1721.
- Thomson RS, Molin NL, Whitehead KJ, Ashby S, Johnson L, Ward PD, McRae BR, Wilson KF, McDonald J (2018). The effects of nasal closure on quality of life in patients with hereditary hemorrhagic telangiectasia. Laryngoscope Investig Otolaryngol, 3(3), 178-181.
- Thomson RS, Molin NL, Whitehead KJ, Ashby S, Johnson L, Ward PD, McRae BR, Wilson KF, McDonald J (2018). The effects of nasal closure on quality of life in patients with hereditary hemorrhagic telangiectasia. Laryngoscope Investig Otolaryngol, 3(3), 178-181.
- Weber LM, McDonald J, Whitehead K (2018). Vitamin D levels are associated with epistaxis severity and bleeding duration in hereditary hemorrhagic telangiectasia. Biomark Med, 12(4), 365-371.
- Girard R, Zeineddine HA, Fam MD, Mayampurath A, Cao Y, Shi C, Shenkar R, Polster SP, Jesselson M, Duggan R, Mikati AG, Christoforidis G, Andrade J, Whitehead KJ, Li DY, Awad IA (2017). Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations. Transl Stroke Res, 9(1), 34-43.
- Akers A, Al-Shahi Salman R, A Awad I, Dahlem K, Flemming K, Hart B, Kim H, Jusue-Torres I, Kondziolka D, Lee C, Morrison L, Rigamonti D, Rebeiz T, Tournier-Lasserve E, Waggoner D, Whitehead K (2016). Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery, 80(5), 665-680.
- Whitehead KJ, Sautter NB, McWilliams JP, Chakinala MM, Merlo CA, Johnson MH, James M, Everett EM, Clancy MS, Faughnan ME, Oh SP, Olitsky SE, Pyeritz RE, Gossage JR (2016). Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial. JAMA, 316(9), 943-51.
- Hunter BN, Timmins BH, McDonald J, Whitehead KJ, Ward PD, Wilson KF (2016). An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2. Laryngoscope, 126(4), 786-90.
- McDonald J, Wooderchak-Donahue W, VanSant Webb C, Whitehead K, Stevenson DA, Bayrak-Toydemir P (2015). Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet, 6, 1.
- Gibson CC, Zhu W, Davis CT, Bowman-Kirigin JA, Chan AC, Ling J, Walker AE, Goitre L, Delle Monache S, Retta SF, Shiu YT, Grossmann AH, Thomas KR, Donato AJ, Lesniewski LA, Whitehead KJ, Li DY (2015). Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation, 131(3), 289-99.
- McDonald J, Wooderchak-Donahue W, VanSant Webb C, Whitehead K, Stevenson DA, Bayrak-Toydemir P (2015). Hereditary hemorrhagic telangiectasia: Genetics and molecular diagnostics in a new era. Front Genet, 5(JAN).
- Mleynek TM, Chan AC, Redd M, Gibson CC, Davis CT, Shi DS, Chen T, Carter KL, Ling J, Blanco R, Gerhardt H, Whitehead K, Li DY (2014). Lack of CCM1 induces hypersprouting and impairs response to flow. Hum Mol Genet, 23(23), 6223-34.
- Gounder SS, Kannan S, Devadoss D, Miller CJ, Whitehead KS, Odelberg SJ, Firpo MA, Paine R, Hoidal JR, Abel ED, Rajasekaran NS (2013). Correction: Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training. PLoS One, 8(6).
- Chan AC, Drakos SG, Ruiz OE, Smith ACH, Gibson CC, Ling J, Passi SF, Stratman AN, Sacharidou A, Revelo MP, Grossmann AH, Diakos NA, Davis GE, Metzstein MM, Whitehead KJ, Li DY (2012). Erratum: Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice (Journal of Clinical Investigation (2011) 121, 5 (1871-1881) DOI: 10.1172/JCI44393). J Clin Invest, 122(5), 1948.
- Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, Drakos SG, Jones CA, Zhu W, Marchuk DA, Davis GE, Li DY (2009). Erratum: The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases (Nature Medicine (2009) 15 (177-184)). Nat Med, 15(4), 462.
Review
- Kaufman CS, McDonald J, Balch H, Whitehead K (2022). Pulmonary Arteriovenous Malformations: What the Interventional Radiologist Should Know. [Review]. Semin Intervent Radiol, 39(3), 261-270.
Letter
- Kilian A, Latino GA, White AJ, Ratjen F, McDonald J, Whitehead KJ, Gossage JR, Krings T, Lawton MT, Kim H, Faughnan ME (2023). Reply to Eker et al. Comment on “Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J. Clin. Med. 2023, 12, 2704” [Letter to the editor]. J Clin Med, 12(23).
Video/Film/CD/Web/Podcast
- Cure HHT (2019). Dr Whitehead's Interview Highlighting Utah HHT Center [Video]. Pompano Beach, Florida: Cure HHT.
He is a very caring person and a good listener and wonderful doctor even when giving not so great news
Dr. Whitehead is an expert on HHT. He is always willing to share his knowledge. He is a great listener, too.
Dr Whitehead takes the time to answer all your questions. We have never felt rushed during any appointments. We are very impressed with Dr Whitehead.
I've had to have lots of doctors and specialist and I've always been impressed with him and his willingness to listen and explain things well
Andrea really likes Dr. Whitehead and the way he explains things to her. (Her mom appreciates this too !) She has been going to him for many years and trusts him totally. Thank you for all your care.
Dr. Whitehead is very caring, attentive, and thoughtful in his approaches. He takes time to explain and answer any questions that the patient has.
Knowledgeable, patient and helpful. He listens and creates a plan to move forward.
Dr Whitehead is top notch for cardiac follow up for my special needs son with congenital heart issues. He is very caring and thoughtful in his treatment approach
Dr Whitehead is a knowledgeable and kind physician. I felt completely comfortable speaking with him.
Dr. Whitehead is a wonderful doctor. If you need his services you're in great hands.
It's been very good since I met him and he's treated me well; I like the attention he gives me. [TRANSLATED]
Excellent, caring doctor. Knows his stuff too.
Dr. Whitehead always treats me respectfully and speaks to me on a level that meets my expectations. He let's me know of any concerns he might have about my situation and listens carefully if I have questions or concerns of my own. I certainly hope he isn't considering retiring anytime soon.
The Knowledge and abilities of Dr. Whitehead are first rate! Always treats with respect and open to questions! Explains in a easy to understand manner!
Amazing HHT healthcare Doctor
Dr. Whitehead is the greatest doctor I've ever been to in my life, especially with my health concerns. He is thorough, polite respectful and takes his time with you and he is excellent in his position as a doctor at the U of U cardiology in the Hht Center!!!!
Caring ,exceptionally talented Doctor.
Excellent in all respects!
Will share with referring physician
Dr Whitehead is professional, personable, and very informative! We seriously love the man! Best cardiologist ever!
He is an expert in HHT and we value that expertise! He and his staff are very caring and do their best to make time for us, as we live in Billings, MT. He is friendly and goes the extra mile to do what is best for his patients (even tho he sees them infrequently) and in working with other doctors!
Dr W was very patient with answering our questions and we didn't feel rushed during our virtual visit. He was concerned about the labs and is working with us to get what we need done here in Idaho. We really appreciate his time and concern
Dr. Whitehead and the staff in the Cardiology department are excellent.
Good experience [TRANSLATED]
I think I would be hard pressed to find a more informed HHT doctor. He is so easy to talk to and I always go away knowing more about HHT than I did before talking to him.
Dr. Whitehead is amazing with his knowledge and TIME with HHT! with all it's complexity's. He listens and provides answers when he can & if he doesn't know the answer is great at finding out one. I appreciate his service as one of a team of Docs I have. He being the leader for other docs as well to explain things when needed! Thank you Dr. Whitehead!
Fantastic caregiver.
Doctor Whitehead is wonderful. He truly cares about people.
Dr Whitehead is very knowledgeable in the information about HHT.i did a lot of different tests before the visit. I feel unanswered questions would have been completely answered if DNA Testing was completed before our visit. That way I would have a more informed outcome. As it is I'm still looking for answers.
Thoroughly explained what he felt would be important for me to stay healthy. Appreciate the time he took for this.
I suffer from a genetic bleeding disorder called HHT. I have been to several physicians all over the country to be treated for more than 50 years. Dr Whitehead is without a doubt the doctor that I feel has been most helpful to me and my family in not only treating me but in following up on my progress. I am very thankful to Dr Whitehead as well as the Hereditary Hemorrhagic Telangiectasia Organization for making it possible for me to become the longest lived member of my family so far. Several members of my family travel from both the East Coast & West Coast to be treated by Dr Whitehead. Thank you Dr Whitehead for all the care you have given to not only me and my family but others who also suffer with HHT.
Very knowledgeable and friendly. Included me in all the discussions and decision making. Made sure that I understood everything we talked about. Gave me access to all his knowledge, and we looked at all the factors together.